Treatment of ulcerative colitis with betamethasone phosphate enemas was found to cause suppression of the adrenal cortex, so that absorption of betamethasone from the rectum can be inferred; no suppression occurred in similar patients treated with prednisolone phosphate enemas (Matts, Wharton, Kelleher, and Walters, 1963) . In order to determine whether any rectal absorption of prednisolone does occur, we have estimated the unconjugated prednisolone and metabolites in the urine of such patients.
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Materials and Method
Studies were made on four patients with ulcerative colitis treated with prednisolone phosphate enemas, and on three normal subjects and two other patients with a collagen disease given oral prednisolone phosphate.
The patients with ulcerative colitis were studied during the first two days of treatment, which then consisted of one enema containing 20 mg. of prednisolone morning and night. Two 24-hour collections of urine were obtained, and in one patient a third collection was also obtained during the 24 hours immediately preceding the first dose.
The three normal subjects took a single oral dose containing 20 mg. of prednisolone dissolved in water, and urine was collected over the next 24 hours; in two of them a 24-hour collection was also obtained before prednisolone was taken.
The other two patients used as controls were being treated with 60 mg. of oral prednisolone daily, and a single 24-hour collection was obtained during treatment.
Prednisolone in urine was estimated by the method of Bailey, Murphy, and West (1961, 1963) . Aliquots of urine containing about 20 jig. of prednisolone were extracted with 4 --volumes of ether: ethyl acetate (2: 1, v/v), and, after washing, the extracts are evaporated to small volume. Standard procedures for quantitative steroid chromatography were used (Bush, 1961) . After a preliminary separation with benzene:methanol:water (2: 1: 1, v/v), a final resolution was made with toluene: methanol: water (4: 3:1, v/v). Standards and unknowns were located with ultra-violet light of wavelength 253 m~i, and then eluted and estimated spectrophotometrically after reaction with isonicotinic acid hydrazide (Umberger, 1955 In the five control subjects the mean excretion of free prednisolone in 24 hours was 12.2% of the dose, with a range of 8.5 to 14.8%. The total excretion of prednisolone plus unconjugated metabolites was determined in the three normal subjects, and this ranged from 12.3 to 23.2%, with a mean of 17.0% of the dose. Lower values were found in the urine of patients given enemas (Table II) . The 24-hour excretion of prednisolone averaged 1.8% of the dose (range 0.1 to 4.0%) and the total of prednisolone plus free metabolites averaged 3.6% (range 0.8 to 8.4%). In two cases there was a large difference between the two days.
Discussion
The absorption of prednisolone from the upper gastrointestinal tract has been studied with isotopically labelled prednisolone. More than 90% of the radioactivity was recovered from the urine by Sandberg and Slaunwhite (1957) , and 98-99% by Vermeulen (1959) , indicating that absorption was Ulcerative Colitis-Wood et al.
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virtually complete. Unconjugated steroids were found to represent only a small part of the total excretion, but Bailey et al. (1961, 1963) observed that the amount of free prednisolone excreted was proportional to the dose given, and that excretion of free prednisolone was almost complete in eight hours (personal communication). With doses of up to 100 mg. approximately 10% of the dose was excreted as free prednisolone, and the results in our controls, which were obtained with basically the same method, are in agreement with this.
The results in the patients with ulcerative colitis show that prednisolone is absorbed to a variable extent from the rectum, but in relatively small amounts. The average excretion of free prednisolone in four patients was approximately one-sixth of that found after oral administration. The variation was much greaser than in the subjects who took prednisolone orally, possibly owing to variations in the time of retention, although all the patients succeeded in retaining the enemas for at least two hours, which is thought to be the minimum time necessary therapeutically. In only one of the eight 24-hour periods was the urine prednisolone more than 3% of the dose given, and the highest value of 4% is about one-third of the mean found after the oral dosage. Even this is less than the equivalent of 7 mg. of oral prednisolone for most of the therapeutic period, and is very unlikely to account for the efficacy of rectal treatment or to cause pituitary or adrenal cortical suppression.
We cannot say whether the suppression which follows treatment with betamethasone enemata is due to the more powerful suppressing effect of betamethasone or whether the rectal mucosa absorbs betamethasone to a greater extent. It has been suggested (Tewfik, 1963) that pain related to the administration of suxamethonium chloride is comparatively uncommon after E.C.T. Pain of this type occurring after operations in women where this drug has been used was first noted by Currie (1953) . Later investigations report an incidence which varies from 20% (Hegarty, 1956) to around 70% (Churchill-Davidson, 1954 ; Morris and Dunn, 1957) . It seems to be generally agreed that the symptom is commonest in out-patients and can be prevented to a certain extent by postoperative bed-rest (Burtles and Tunstall, 1961) . These findings in patients who have had operations or been investigated under anaesthesia cast doubt on the clinical impression of a lowered incidence of muscular pain after suxamethonium chloride and E.C.T., as those receiving this treatment are often out-patients and nearly always ambulant. In view of this a prospective study of the incidence of pain in patients receiving suxamethonium chloride and E.C.T. has been carried out.
Patients undergoing electroplexy sometimes complain of headache after the treatment. All the clinical reports of pain after administration of suxamethonium chloride agree that the pain is muscular, occurring in the back, chest, and limbs. We can therefore examine the incidence of both headache and muscular pains and their relation to treatment.
Method
All patients starting a course of E.C.T. between 17 September and 24 December 1963 were interviewed during the study. Four out-patients were omitted because the erratic nature of their attendance prevented adequate assessment. The results are derived from the findings on 47 patients (22 male and 25 female) aged 16-74 years (mean 41.62 years) who underwent a total of 259 anaesthetics and treatments.
Treatment was carried out twice a week and patients were interviewed on treatment days, before the arrival of the anaesthetist. They were told that the object of the investigations was to examine the possible side-effects of E.C.T. Attention was primarily directed to subjective loss of memory, and information about physical symptoms, including pain, was sought secondarily. Nevertheless, when pain was not reported spontaneously direct questions were asked, put in the form which " expects the answer no." The site, characteristics, and relation to treatment of the various pains reported were recorded. Muscular pain occurring after treatment in the neck, trunk, and limbs was regarded as related to the administration of suxamethonium chloride. Headache is considered separately. The presence of other pain related to the patient's illness was noted.
An Ectron machine was used to administer E.C.T. and the stimulus was given alternately by an "instant" or a " glisssando" method, as it was thought possible that the
